TreatmentUpdate 72, Vol. 8, No. 8; October 1996
Sean Hosein

Doctors in the US recruited 323 HIV-infected women who had less than 300 CD4+ cells for this study. One hundred and sixty-two received fluconazole 200 mg/week and 161 received fake fluconazole (placebo). Researchers monitored 50% of subjects for 2 and a half years.

Results

Thirteen subjects developed yeast infections; 6 in the fluconazole group and 7 in the placebo group.

REFERENCES:

1. Vasquez JA, Steel-Moore L, Schuman P, et al . Antifungal susceptibility among Candida species recovered from HIV-positive women receiving fluconazole prophylaxis. Abstract LB10.

961020
CATE7207

Copyright © 1996 - TreatmentUpdate. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, The Canadian AIDS Treatment Information Exchange, 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284  http://www.catie.ca